Stock Earnings

Question 1

What are Claritas Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Claritas Pharmaceuticals Inc has a total asset of $10, Net profit of $4

Question 2

What are the key financial ratios for CLAZF?

Accepted Answer

Claritas Pharmaceuticals Inc's Current ratio is 1.25, has a Net margin is 0, sales per share of $0.

Question 3

How is Claritas Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Claritas Pharmaceuticals Inc data is not available.

Question 4

Is Claritas Pharmaceuticals Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Claritas Pharmaceuticals Inc has a net profit of $4

Question 5

Does Claritas Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Claritas Pharmaceuticals Inc has liability of 8

Question 6

How many outstanding shares for Claritas Pharmaceuticals Inc?

Accepted Answer

Claritas Pharmaceuticals Inc has a total outstanding shares of 27.3

Breakdown	TTM	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	1	1	3	3	3	3
Research & Development	--	-2	5	7	1	1
Operating Expenses	0	-12	-7	4	4	5
Other Non Operating Income (Expenses)	-2	0	0	-2	-17	0
Pretax Income	-1	0	-25	6	-31	-11
Income Tax Expense	0	-4	-4	0	0	0
Net Income	-4	4	-21	6	-31	-11
Net Income Growth	33%	-119%	-450%	-119%	182%	--
Shares Outstanding (Diluted)	35.41	26.69	22.44	10.91	6.2	1.47
Shares Change (YoY)	31%	19%	106%	76%	322%	1,251%
EPS (Diluted)	-0.13	0.16	-0.95	0.64	-5.13	-7.86
EPS Growth	0%	-117%	-248%	-112%	-35%	773%
Free Cash Flow	0	0	-6	-4	-5	-1
Free Cash Flow Per Share	0	0	-0.26	-0.36	-0.8	-0.68
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	--	--	--	--	--	--
EBITDA Margin	--	--	--	--	--	--
D&A For EBITDA	--	--	--	--	--	--
EBIT	0	12	7	-4	-4	-5
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	16%	0%	0%	0%

Claritas Pharmaceuticals Inc (CLAZF) Price